Botox Should NOT Be Used for TMJ Pain
Based on the most recent and highest quality evidence, botulinum toxin injection is conditionally recommended AGAINST for chronic TMD pain, and there is no established "usual dose" because it should not be routinely offered. 1
Why Botox Is Not Recommended
The 2023 BMJ clinical practice guideline—the most authoritative and recent evidence available—explicitly places botulinum toxin injection in the "conditional recommendations against" category for chronic TMD pain 1. This means:
- The benefits on pain relief and function are uncertain
- The intervention is associated with harms or burden
- Most informed patients would likely not want this treatment when presented with the evidence
The Evidence Behind This Recommendation
The guideline is based on a systematic review and network meta-analysis of all available interventions for chronic TMD pain. While some older studies suggested potential benefit, the overall body of evidence does not support routine use 1.
Recent research confirms this position:
- A 2024 randomized controlled trial using 50 units of Botox found no significant difference between Botox and saline placebo for pain intensity or pain-related disability, though Botox did impair muscle function 2
- A 2011 multicenter RCT using 50 units showed the number needed to treat was 11 at one month and 7 at three months—indicating minimal clinical benefit 3
- A 2024 meta-analysis concluded that BTX-A was not significantly better than placebo for pain reduction at 1,3, and 6 months 4
What Doses Have Been Studied (For Context Only)
Since you asked about dosing, the literature shows wide variation with no consensus 5:
- Botox (onaBoNT-A): 30-150 units total, typically divided between masseter and temporalis muscles
- Dysport (aboBoNT-A): 50-300 units per muscle 5
However, this lack of standardization itself reflects the absence of proven efficacy—if Botox were clearly effective, a standard dose would have emerged.
What SHOULD Be Offered Instead
The same 2023 BMJ guideline provides strong recommendations in favor of these interventions 1:
- Cognitive behavioral therapy (with or without biofeedback)
- Supervised jaw exercises and stretching
- Manual trigger point therapy
- Supervised postural exercises
- Therapist-assisted mobilization
- Usual care (home exercises, stretching, reassurance, education)
These interventions have demonstrated benefits that clearly outweigh harms.
Clinical Pitfall to Avoid
Do not offer Botox as a first-line or routine treatment for TMD pain. If a patient specifically requests it after failing conservative therapies, shared decision-making is essential—they must understand that evidence shows it performs no better than placebo for pain relief while causing measurable muscle weakness 2, 3.